KRN951, a Highly Potent Inhibitor of Vascular Endothelial Growth Factor Receptor Tyrosine Kinases, Has Antitumor Activities and Affects Functional Vascular Properties-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

KRN951, a Highly Potent Inhibitor of Vascular Endothelial Growth Factor Receptor Tyrosine Kinases, Has Antitumor Activities and Affects Functional Vascular Properties

Published:2006-09-15 Issue:18 Volume:66 Page:9134-9142
ISSN:0008-5472
Container-title:Cancer Research
language:en
Short-container-title:Cancer Res

Author:

Nakamura Kazuhide,Taguchi Eri,Miura Toru,Yamamoto Atsushi,Takahashi Kazumi,Bichat Francis,Guilbaud Nicolas,Hasegawa Kazumasa,Kubo Kazuo,Fujiwara Yasunari,Suzuki Rika,Kubo Kinya,Shibuya Masabumi,Isae Toshiyuki

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 194 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phase I Study of Tivozanib Eye Drops in Healthy Volunteers and Patients with Neovascular Age-Related Macular Degeneration;Ophthalmology Science;2024-11

2. VEGF-A165a and angiopoietin-2 differently affect the barrier formed by retinal endothelial cells;Experimental Eye Research;2024-10

3. Tivozanib plus nivolumab versus tivozanib monotherapy in patients with renal cell carcinoma following an immune checkpoint inhibitor: results of the phase 3 TiNivo-2 Study;The Lancet;2024-09

4. Overcoming Secondary Mutations of Type II Kinase Inhibitors;Journal of Medicinal Chemistry;2024-06-05

5. A real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events for Tivozanib;2024-04-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP